Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 27, 2026 08:00 ET | Source: Freenome, Inc.

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
July 20, 2026 16:01 ET | Source: Freenome, Inc.

Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection

Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection